MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars) _ Neurodegenerative; Neuromuscular, Neuropsychiatric
Orphazyme A/S (NASDAQ: ORPH)
Organization & Developments: Orphazyme
Parents
Orphazyme A/S (NASDAQ: ORPH)
Children
2022: From Redditors to creditors: Orphazyme's wild ride ends with $13M sale to satisfy bankruptcy court
Company Description: A biotechnology company focused on the development of therapies for lysosomal storage diseases
Focused on making use of the cell-protective properties of HSP70 to create new therapies for rare neurodegenerative diseases.
Jumps
Finance & Acquisitions: Orphazyme
Key People: Orphazyme